Trends in Cardiovascular Medicine
Volume 19, Issue 3 , Pages 87-94, April 2009

Will the Real Plaque Vasculature Please Stand Up? Why We Need to Distinguish the Vasa Plaquorum From the Vasa Vasorum

  • Zorina S. Galis

      Affiliations

    • Department of Surgery, Indiana University, and Amplinovia, Indianapolis, IN 46236, USA
  • ,
  • Susan M. Lessner

      Affiliations

    • Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, SC 29209, USA
    • Corresponding Author InformationAddress correspondence to: Dr. Susan M. Lessner, University of South Carolina School of Medicine, 6439 Garners Ferry Rd., Bldg 1, Room. C-38, Columbia, SC 29209, USA. Tel.: (+1) 803 733 1503; fax: (+1) 803 733 3153.

Many studies of experimental atherosclerosis and pathologic observations of human specimens have provided evidence supporting a correlation between vascularization of the atherosclerotic plaque and its natural growth and progression toward acute failure, associated with clinical events. The growing interest in the topic is illustrated by several excellent recent reviews discussing the molecular mechanisms that might play a role in the formation of plaque vasculature and that could explain some of the observed associations with pathologic features of experimental and human atherosclerotic lesions. At the same time, these reviews also emphasize that the field is still largely in uncharted territory. Hoping to spark some new investigations, we are taking this opportunity to question some of the common assumptions and to highlight less explored mechanisms. Finally, we are proposing to adopt the term vasa plaquorum to refer to the neovasculature located within the atherosclerotic plaque to distinguish it clearly from vasa vasorum, the native, supporting vasculature of the artery. We suggest that this new nomenclature offers a potential solution to eliminate ambiguity regarding implicit, but frequently neglected, differences between these structures. We think these points are relevant for future efforts to tailor diagnostic tools and therapeutic interventions targeting plaque neovascularization for the clinical management of atherosclerosis.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(09)00086-3

doi:10.1016/j.tcm.2009.06.001

Trends in Cardiovascular Medicine
Volume 19, Issue 3 , Pages 87-94, April 2009